# Thyrocare Technologies Ltd (THYROCARE)
> Exchange: NSE | Sector: Healthcare | ISIN: 

## Price
Current Price: ₹469.05
Day Change: -1.3%
52W High: ₹536.67
52W Low: ₹291.37
Market Cap: ₹7,197 Cr

## Valuation
P/E: 44.07
P/B: 13.46
EPS: ₹10.26
Book Value: ₹33.6
Dividend Yield: 2.02%

## Returns
1Y Return: -3.01%

## Profitability
ROE: 28.75%
ROCE: 36.25%
Debt/Equity: 0.09
Revenue Growth: 19.7%
Profit Growth: 116.4%
EBITDA Margin: 31.61%
Operating Margin: 27.27%

## About
Thyrocare Technologies Ltd is a Diagnostics & Research company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Healthcare
Industry: Diagnostics & Research
Sub Industry: Unknown

## Business Model
Overview: Thyrocare Technologies Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Diagnostics & Research. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Healthcare.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Concall Transcript: Announcement under Regulation 30 (LODR)-Earnings Call Transcript
- Announcement: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- GuruFocus.com: Thyrocare Technologies Ltd (BOM:539871) Q4 2026 Earnings Call Highlights: Strong Revenue Growth ...

## Access
Current tier: anonymous
More history: Register free to see 8 more years.

## Data Freshness
Quote Updated: 2026-05-21T20:00:05.656Z
Price History Updated: 2026-05-18T22:58:31.465Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:58:31.465Z
Quant Updated: 2026-05-18T22:58:31.465Z
Sentiment Updated: 2026-05-18T22:58:31.465Z
Financials Status: current
Financials Updated: 2026-05-18T12:30:08.505Z
Financials Last Attempt: 2026-05-18T12:30:08.505Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2016)
Revenue: ₹183 Cr
Operating Profit: ₹73 Cr (OPM 40%)
Net Profit: ₹44 Cr
Tax: ₹68 Cr

## Annual P&L History
Mar 2016: Rev ₹183Cr | PAT ₹44Cr | OPM 40%
Mar 2017: Rev ₹241Cr | PAT ₹52Cr | OPM 39%
Mar 2018: Rev ₹304Cr | PAT ₹43Cr | OPM 38%

## Balance Sheet (Mar 2016)
Total Assets: ₹329 Cr
Total Liabilities: ₹329 Cr
Borrowings: ₹0 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Rahul Franklin Guha, MD, CEO & Chairman
- Brijesh  Kumar, Company Secretary & Compliance Officer
- Vikram  Gupta, Chief Financial Officer
- Ramesh  Kinha, Chief Operating Officer
- Pratik  Hire, Head of Strategy & Investor Relations

---
Source: rupiya.io/stocks/thyrocare
Disclaimer: For research and education only. Not investment advice.